The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -69.84%. However, over the last six months, the performance has been stronger by -99.67%. The price of UPC decreased -71.25% over the last 30 days. And in the last five days, it has fallen by -54.57%.
Universe Pharmaceuticals INC saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $64.80 on 07/09/24, while the lowest price for the same duration was marked at $0.14 on 02/06/25.
52-week price history of UPC Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Universe Pharmaceuticals INC’s current trading price is -99.72% away from its 52-week high, while its distance from the 52-week low is 29.58%. The stock’s price range during this period has varied between$0.14 and $64.80. The Universe Pharmaceuticals INC’s shares, which operate in the Healthcare, saw a trading volume of around 143.23 million for the day, a figure considerably higher than their average daily volume of 2.94 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Universe Pharmaceuticals INC (UPC) has experienced a quarterly decline of -95.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.59M.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.4751, with a change in price of -7.9760. Similarly, Universe Pharmaceuticals INC recorded 3,311,527 in trading volume during the last 100 days, posting a change of -97.75%.
UPC’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for UPC stands at 0.24. Similarly, the long-term debt-to-equity ratio is also 0.08.
UPC Stock Stochastic Average
Universe Pharmaceuticals INC’s raw stochastic average for the past 50 days is presently 0.88%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 7.82%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 5.49% and 4.94%, respectively.
